PL101 ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
8Huntington disease5

8. Huntington disease


Clinical trials : 229 Drugs : 193 - (DrugBank : 60) / Drug target genes : 84 - Drug target pathways : 158
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2020-002822-10-NL
(EUCTR)
26/02/202124/11/2020A study of Pridopidine in Patients with Early Stage of Huntington DiseaseA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter Study Evaluating the Efficacy and Safety of Pridopidine in Patients with Early Stage of Huntington Disease - PRidopidine Outcome on Function in Huntington Disease (PROOF-HD) Huntington Disease
MedDRA version: 20.0;Level: PT;Classification code 10070668;Term: Huntington's disease;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Product Name: Pridopidine
Product Code: PL101
INN or Proposed INN: PRIDOPIDINE HYDROCHLORIDE
Other descriptive name: Pridiopidine
Prilenia Neurotherapeutics Ltd.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
480Phase 3Austria;Czech Republic;Germany;Netherlands
2EUCTR2020-002822-10-CZ
(EUCTR)
21/01/202110/11/2020A study of Pridopidine in Patients with Early Stage of Huntington DiseaseA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter Study Evaluating the Efficacy and Safety of Pridopidine in Patients with Early Stage of Huntington Disease - PRidopidine Outcome on Function in Huntington Disease (PROOF-HD) Huntington Disease
MedDRA version: 20.0;Level: PT;Classification code 10070668;Term: Huntington's disease;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Product Name: Pridopidine
Product Code: PL101
INN or Proposed INN: PRIDOPIDINE HYDROCHLORIDE
Other descriptive name: Pridiopidine
Prilenia Neurotherapeutics Ltd.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
480Phase 3Canada;Austria;Netherlands;Germany;United Kingdom;United States;Czech Republic;European Union
3EUCTR2020-002822-10-AT
(EUCTR)
18/01/202109/11/2020A study of Pridopidine in Patients with Early Stage of Huntington DiseaseA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter Study Evaluating the Efficacy and Safety of Pridopidine in Patients with Early Stage of Huntington Disease - PRidopidine Outcome on Function in Huntington Disease (PROOF-HD) Huntington Disease
MedDRA version: 20.0;Level: PT;Classification code 10070668;Term: Huntington's disease;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Product Name: Pridopidine
Product Code: PL101
INN or Proposed INN: PRIDOPIDINE HYDROCHLORIDE
Other descriptive name: Pridiopidine
Prilenia Neurotherapeutics Ltd.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
480Phase 3United States;Czech Republic;European Union;Canada;Austria;Netherlands;Germany;United Kingdom
4EUCTR2020-002822-10-DE
(EUCTR)
11/12/202006/11/2020A study of Pridopidine in Patients with Early Stage of Huntington DiseaseA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter Study Evaluating the Efficacy and Safety of Pridopidine in Patients with Early Stage of Huntington Disease - PRidopidine Outcome on Function in Huntington Disease (PROOF-HD) Huntington Disease
MedDRA version: 20.0;Level: PT;Classification code 10070668;Term: Huntington's disease;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Product Name: Pridopidine
Product Code: PL101
INN or Proposed INN: PRIDOPIDINE HYDROCHLORIDE
Other descriptive name: Pridiopidine
Prilenia Neurotherapeutics Ltd.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
480Phase 3United States;Czech Republic;European Union;Canada;Austria;Netherlands;Germany;United Kingdom
5EUCTR2020-002822-10-IT
(EUCTR)
23/11/202024/05/2021A study of Pridopidine in Patients with Early Stage of Huntington DiseaseA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter Study Evaluating the Efficacy and Safety of Pridopidine in Patients with Early Stage of Huntington Disease - PRidopidine Outcome on Function in Huntington Disease (PROOF-HD) Huntington Disease
MedDRA version: 20.0;Level: PT;Classification code 10070668;Term: Huntington's disease;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Product Name: Pridopidine
Product Code: [PL101]
INN or Proposed INN: PRIDOPIDINE HYDROCHLORIDE
Prilenia Neurotherapeutics LtdNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
480Phase 3United States;Czech Republic;European Union;Canada;Austria;Netherlands;Germany;United Kingdom;Italy